*** SCHEDULE & PROGRAM ***
(updated on October 9, 2009)
Please note that this program may be updated at any time by the organizers
You are suggested to prepare your lecture ppt under the version of software 'Office 2003' or 'Office 2007'
|
Sunday, October 18, 2009 |
16:00-19:00 Registration and Poster setup
19:00-19:15 Summary of Conference Preparation - Jianhua Wang (Beijing, P. R. China)
19:30-21:30 Welcome Evening Buffet
|
Monday, October 19, 2009 |
08:50-09:10 Student Award Ceremony / Opening Remarks
Members of International Scientific Committee and Local
Organizing Committee of 9th ILC
|
Session I - Lactoferrin structure-function relationships |
09:10-09:40 Edward N. Baker (Auckland,New Zealand)
Focusing a high-resolution lens on the structure of lactoferrin
09:40-10:00 Hardiville Stephan (Villeneuve d’Ascq cedex, France)
The O-GlcNAc/phosphate interplay regulates both delta-lactoferrin stability and transcriptional activity
10:00-10:20 Benjamin Ashby (Sydney, Australia)
Structural modifications to bovine lactoferrin and their effects on promotion of corneal epithelial wound healing in vitro
10:20–10:40 Masaru Tanokura (Tokyo, Japan)
Studies of the structure of multiferric ion-bound lactoferrin: a new antianemic edible material
10:40-11:20 Coffee Break-Posters
| Poster Pan Fenggang (Tokyo, Japan) Studies of the structure of multiferric ion-bound lactoferrin: a new antianemic edible material |
|
Session II - Lactoferrin ligands / receptors |
11:20-11:50 Bo Lonnerdal (Davis, CA, USA)
Lactoferrin receptor mediates cellular activities of lactoferrin
11:50-12:20 Annick Pierce (Villeneuve d’Ascq, France)
Human delta-lactoferrin is a transcription factor which regulates cell survival
12:20-12:40 Frank Mao (Taichung, Taiwan, China)
Chromium-Lactoferrin complex supplementation ameliorates nonalcoholic fatty liver disease in mice
12:40-13:00 Zhihong Liu (Calgary, Alberta, Canada)
Interactions between lactoferrin and regulatory calcium binding proteins
13:10-15:00 Lunch Time
|
Session III - Regulation of cell proliferation and differentiation by lactoferrin |
15:00-15:30 Sang-Yun Choi (Seoul, Korea South)
Cell stress-responsive lactoferrin in growth control signaling
15:30-15:50 Yoshiharu Takayama (Tsukuba Ibaraki, Japan)
Regulation of osteogenic and chondrogenic differentiation by lactoferrin
15:50-16:10 Mattias Münnich (Goteborg, Sweden)
A novel polypeptide derived from human lactoferrin prevents post-surgical adhesion formation
16:10-16:30 Hongrui Jiang (Harbin, P. R. China)
Structure-function relationship of synthetic peptides homologous to a loop structure on bovine lactoferricin apoptosis in jurkat cells
16:30-17:10 Coffee Break-Posters
Posters
Anthony Schryvers (Calgary, Alberta, Canada)
Structural and functional features of lactoferrin binding B from Gram-negative pathogens
Hong Tian (Auckland, New Zealand )
Evaluation of the cytoprotective effects of bovine bactoferrin against intestinal toxins using cellular model systems
Tienan Zhang (Harbin, P. R. China)
Structure-function relationship of synthetic peptides homologous to a loop structure on bovine lactoferricin apoptosis in jurkat cells
|
Session IV - Immunomodulating effects of lactoferrin |
17:10-17:40 Jillian Cornish (Auckland, New Zealand)
Lactoferrin as an effecter molecule in the skeleton
17:40-18:00 Dominique Legrand (Villeneuve d'Ascq cedex, France)
A review of the roles of lactoferrin in immunity
18:00-18:20 Anne van der Does (Leiden, The Netherlands)
Modulation of the immune system by the lactoferrin-derived peptide hLF1-11
18:20-18:40 Satoru Morishita (Tokyo, Japan)
Potent anti-adipogenic action of enteric-coated lactoferrin: alteration of gene expression profiles of pre-adipocyte derived from rat mesenteric fat by lactoferrin
| Posters Yu Kataoka (Tokyo, Japan) Original ointment mixed with lactoferrin having anti-inflammatory activity in vivo Esthelle Hoedt (Villeneuve d'Ascq, France) The use of TaqMan real time PCR to discriminate and evaluate the variation in lactoferrin and delta-lactoferrin expression levels Sandra Gessani (Rome, Italy) Immunomodulatory effects of lactoferrin in antigen presenting cells |
19:00-21:45 Reception Dinner of New Baili
19:10-19:40 Going to the Bianyifang Anhua Duck Restaurant by the conference bus.
19:45-21:45 Reception Dinner of New Baili (NBL)
21:45-22:30 Getting on the conference bus and return to Beijing Friendship Hotel
|
Tuesday, October 20, 2009 |
|
Session V - Lactoferrin in pathologies |
09:00-09:30 Piera Valenti ( Rome, Italy)
Lactoferrin in curing hypoferremia and anaemia: mechanism of action
09:30-09:50 Arnaud Malet (France)
Bovine Lactoferrin improves bone status of ovariectomized mice via immune function modulation
09:50-10:10 Fabiana Superti (Rome, Italy)
Lactoferrin treatment inhibits influenza virus infection in vitro
10:20-11:00 Coffee Break-Posters
| Posters Hong Tian (Auckland, New Zealand) Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens Inger Mattsby-Baltzer (Bucharest, Romania) Anti-tumor capacity of liposome-entrapped lactoferrin: basic research and future opportunities Magda Marchetti (Rome, Italy) Bovine lactoferrin interacts with cable pili of Burkholderia cenocepacia Nidia Leon-Sicairos (Sinaloa, México) Vesicular traffic of human holo-transferrin and holo-lactoferrin in Entamoeba histolytica Nidia Leon-Sicairos (Sinaloa, México) Effect of bovine lactoferrin in a murine model of intestinal amoebiasis Piera Valenti (Rome, Italy) Lactoferrin modulates gene expression of cystic fibrosis bronchial cells invaded by iron and zinc-modulated biofilm of Burkholderia cenocepacia clinical isolates |
|
Session V - Lactoferrin in pathologies (continued) |
11:00-11:30 Hans Vogel (Calgary, Alberta, Canada)
Lactoferrin and its interactions with other immuno-modulating, biofluid proteins such as osteopontin
11:30-11:50 Anne Blais (Paris, France)
Bovine lactoferrin ingestion protects bone microarchitecture in ovariectomized mice
|
Session VI - Antimicrobial activity of lactoferrin and lactoferrin-derived protein (peptide) |
11:50-12:20 Anthony Schryvers (Calgary, Alberta, Canada)
Structural and functional features of lactoferrin binding B from Gram-negative pathogens
12:20-12:40 Xuejing Bai (Beijing, P. R. China)
Molecular design, expression and characterization of recombinant bovine lactoferrin-derived antimicrobial protein
12:40-13:00 Susan Mosquito Guillen (Lima, Perú)
Effect of the bovine lactoferrin in Salmonella ser. Typhimurium infection in mice
13:10-15:00 Lunch Time
|
Session VI - Antimicrobial activity of lactoferrin and lactoferrin-derived protein (peptide) (continued) |
15:00-15:30 Nidia Leon-Sicairos (Sinaloa, México)
Bactericidal activity of bovine lactoferrin and LFchimera against antibiotic-resistant Staphylococcus aureus and Escherichia coli
15:30-15:50 Hiroyuki Wakabayashi (Zama Kanagawa, Japan)
Lactoferrin inhibits biofilm and dental plaque of periodontopathic bacteria
15:50-16:10 Yifan Liu (Hangzhou, P. R. China)
Comparative antimicrobial activity in vitro and mechanism of synthetic peptides derived from bovine lactoferricin
16:10-16:40 Coffee Break-Posters
| Posters Elena Sadchikova (Moscow, Russia) Recombinant human lactoferrin dominates antibiotics resistant microorganisms Mai Murata (Zama-City, Japan) Influence of lipopolysaccharides on the antimicrobial activity of lactoferrin against Escherichia coli Nidia Leon-Sicairos (Sinaloa, México) Bactericidal activity of bovine lactoferrin and LFchimera against antibiotic-resistant Staphylococcus aureus and Escherichia coli Nidia Leon-Sicairos (Sinaloa, México) Microbicidal effect of the bovine lactoferrin peptides Lactoferricin, Lactoferrampin and the LFchimera on the parasite Entamoeba histolytica Shaojiang Chen (Hokitika, New Zealand) Low iron bovine lactoferrin with improved antimicrobial activity Sakawrat Kanthawong (Khon Kaen, Thailand) LFchimera, consisting of both antimicrobial lactoferrin domains, is a potent bactericidal agent to combat Burkholderia pseudomallei |
|
Session VII - Molecular design and expression of lactoferrin-derived protein (peptide) |
16:40-17:10 Yalin Yang (Beijing, P. R. China)
Design and expression of lactoferrin-derived peptide
17:10-17:30 Xingjun Feng (Harbin, P. R. China)
Designing, synthesis and antibacterial activity of an antimicrobial peptide LFB15-ME8
17:30-17:50 Yonggang Xie (Hangzhou, P. R. China)
Antibacterial and hemolytic activities of lactoferricin, palustrin-OG1 and cecropin A: a comparative study
17:50-18:40 Dinner time
18:45-22:30 Self-paid Opera (to buy ticket by currency RMB when signing in)
18:45-19:30 Going to the National Centre for the Performing Arts by the conference bus.
19:30-21:30 The Butterfly Lovers - Modern ‘Yue Opera’ (A, Ancient love story, ’Song’ dynasty 352-373AD; B, the ‘Yue opera’ from a Yue State of eastern China, 475-221BC)
21:45-22:30 Getting on the conference bus and return to Beijing Friendship Hotel
|
Wednesday, October 21, 2009 |
|
Session VII - Molecular design and expression of lactoferrin-derived protein (peptide) (continued) |
09:00-09:30 Christina Teng (Raleigh, USA)
Lactoferrin: The path from gene to protein
09:30-09:50 Zhiru Tang (Changsha, P. R. China)
High level fusion expression of bovine lactoferricin and lactoferrampin genes in Photorhabdus luminescens TZR001
09:50-10:10 Frans de Loos (Leiden, The Netherlands)
Stability and safety of production of recombinant human lactoferrin in transgenic cows — A report on 20 years of experience
10:10-10:30 Coffee Break-Posters
| Posters Fu Fan (Hangzhou, P. R. China) Expression and purification the antimicrobial peptide protegrin-1 in E. coli Xuejing Bai (Beijing, P. R. China) Molecular design, expression and characterization of recombinant bovine lactoferrin-derived antimicrobial protein Yalin Yang (Beijing, P. R. China) Expression of a candidacidal peptide lactoferrampin in Escherichia coli Zigang Tian (Beijing, P. R. China) Design and Expression of antimicrobial hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A Zigang Tian (Beijing, P. R. China) Cloning, expression and characterization of Kunming mice lactoferrin and its N-lobe |
|
Session VIII - Recombinant and transgenic lactoferrins |
10:30-11:00 Guoxiang Cheng (Shanghai, P. R. China)
Biosafety assessment of human lactoferrin transgenic goat
11:00-11:20 Zigang Tian (Beijing, P. R. China)
Cloning, expression and characterization of Kunming mice lactoferrin and its N-lobe
11:20-11:40 Ning Huang (Davis California, USA)
Recombinant human lactoferrin production and its application in the management of diarrhea
11:45-12:45 Lunch Time
14:00-18:00 Sponsors meeting - Coordinated by G. X. Cheng, L. Pierson,J.-P. Perraudin, H. Matsumura
12:45-19:30 Self-paid tourism (to buy ticket by currency RMB when signing in)
12:45-13:30 Getting on the conference bus to the Palace Museum at the centre of Beijing
13:30-18:00 Tourism
18:30-19:30 Getting on the conference bus and return to the Beijing Friendship Hotel
19:30-21:30 Gala dinner (your formal or business casual dress would be advised)
|
Thursday, October 22, 2009 |
|
Session VIII - Recombinant and transgenic lactoferrins (continued) |
09:00-09:30 Ning Li (Beijing, P. R. China)
Production of functional recombinant human lactoferrin in the milk of transgenic cloned cattle
09:30-09:50 Huiqin Yu (Shanghai, P. R. China)
Dominant expression of functional human lactoferrin in transgenic goats
| Posters Aliaksandr Budzevich (Zhodino, Minsk region, Belarus) Human lactoferrin transgenic goat breeding Hsiao-Ling Chen (Changhwa, Taiwan, China) Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance Igor Goldman (Moscow, Russia) Recombinant human lactoferrin in the milk of transgenic animals Tian Yu (Beijing, P. R. China) Comparative analysis of the site-specific N-glycosylation of hLF and rhLF expressed in transgenic cloned cattle Xuejing Bai (Beijing, P. R. China) Bovine lactoferrin and its N-lobe produced in recombinant Pichia pastoris demonstrate differences in iron binding and antimicrobial activities Zhiru Tang (Changsha, P. R. China) The expression of mutated bovine lactoferricin gene in Escherichia coli YZ2005 and its antimicrobial activity identification |
|
Session IX - Lactoferrins applications |
09:50-10:20 Kei-ichi Shimazaki (Sapporo, Hokkaido, Japan)
Preliminary approach to overview lactoferrin's multifunctional fields by text mining method
10:20-10:50 Jean-Paul Perraudin (Tubize, Belgium)
Reduction of the biological activities of the lactoferrin by the presence of the endotoxins on its molecular structure
10:50-11:20 Coffee Break – Posters
| Posters Atsushi Ishikado (Takatsuki, Japan) Human trial of liposomal lactoferrin supplementation for periodontal disease Chuan-Mu Chen (Taichuang, Taiwan, China) Lactoferrin as a natural regimen of selective decontamination of the digestive tract Kei-ichi SHIMAZAKI (Tokyo, Japan) Information extraction for an overview of lactoferrin multi-functionality by a text mining method Theresa Ochoa (Lima, Peru) Implementation of a community-based clinical trial of lactoferrin for prevention of diarrhea in children Jean-Paul Perraudin (Tubize, Belgium) Hypothiocyanite and Lactoferrin use for the treatment of Pseudomonas aeruginosa, Burkholderia cepacia and MRSA in cystic fibrosis and respiratory diseases Jeremy H. Brock (Glasgow, UK) An overview of functions of lactoferrin with medical and nutraceutical applications |
|
Session IX - Lactoferrins applications (continued) |
11:10-11:40 Hiroyuki Tsuda (Nagoya, Japan)
Suppressive effect of orally administered bovine lactoferrin on the growth of colorectal polyps in a randomized, placebo-controlled clinical trial
11:40-12:10 Theresa Ochoa (Lima, Peru)
Implementation of a community-based clinical trial of lactoferrin for prevention of diarrhea in children
12:10-12:30 Pilar Mier (Cantabria, Spain)
Optimizing the production of high-added value proteins through Hi-tech separation technologies
12:30-12:50 Koji Yamauchi (Kanagawa, Japan)
Applications of bovine lactoferrin and bovine lactoferrin hydrolyzate
12:50-13:05 Genevieve Spik Award Ceremony — Bo Lonnerdal (Davis, CA, USA)
13:05-13:20 Concluding remarks — Annick Pierce (Villeneuve d’Ascq, France)
13:20-14:45 Lunch time
|
Session X - Open Round Table Meeting |
15:00-18:00 A discussion on perspective of cooperation & coordination for lactoferrin R & D
18:30-20:30 Buffet dinner
More detail information on tourism can be seen from the following websites:
The Palace museum, the Great Wall in Beijing and other popular tourist destinations out of Beijing are detailed in the following websites:
http://www.muztagh.com/beijing/
http://www.travel-images.com/china.html
http://www.travelchinaguide.com/